BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38460487)

  • 1. Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A.
    Lee H; Kim E; Hwang N; Yoo J; Nam Y; Hwang I; Park JG; Park SE; Chung KS; Won Chung H; Song C; Ji MJ; Park HM; Lee IK; Lee KT; Joo Roh E; Hur W
    Bioorg Med Chem; 2024 Mar; 102():117658. PubMed ID: 38460487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.
    Janeček M; Rossmann M; Sharma P; Emery A; Huggins DJ; Stockwell SR; Stokes JE; Tan YS; Almeida EG; Hardwick B; Narvaez AJ; Hyvönen M; Spring DR; McKenzie GJ; Venkitaraman AR
    Sci Rep; 2016 Jun; 6():28528. PubMed ID: 27339427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the design of allosteric inhibitors of the Aurora kinase A enzyme in the cancer chemotherapy.
    de Souza VB; Kawano DF
    Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129448. PubMed ID: 31676293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Targeting of Aurora A Kinase Using Small Molecules: A Step Forward Towards Next Generation Medicines?
    Panicker RC; Coyne AG; Srinivasan R
    Curr Med Chem; 2019; 26(13):2234-2242. PubMed ID: 28748768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinase-independent function for AURORA-A in replisome assembly during DNA replication initiation.
    Guarino Almeida E; Renaudin X; Venkitaraman AR
    Nucleic Acids Res; 2020 Aug; 48(14):7844-7855. PubMed ID: 32652013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.
    Durlacher CT; Li ZL; Chen XW; He ZX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):585-601. PubMed ID: 26999067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2.
    Li H; Wang Y; Lin K; Venkadakrishnan VB; Bakht M; Shi W; Meng C; Zhang J; Tremble K; Liang X; Song JH; Feng X; Van V; Deng P; Burks JK; Aparicio A; Keyomarsi K; Chen J; Lu Y; Beltran H; Zhao D
    Cancer Res; 2022 Sep; 82(17):3088-3101. PubMed ID: 35771632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in interpreting the in vivo activity of Aurora-A.
    Shagisultanova E; Dunbrack RL; Golemis EA
    Expert Opin Ther Targets; 2015 Feb; 19(2):187-200. PubMed ID: 25384454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA).
    Hijjawi MS; Abutayeh RF; Taha MO
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33353031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights.
    Al-Sanea MM; Elkamhawy A; Paik S; Lee K; El Kerdawy AM; Syed Nasir Abbas B; Joo Roh E; Eldehna WM; Elshemy HAH; Bakr RB; Ali Farahat I; Alzarea AI; Alzarea SI; Alharbi KS; Abdelgawad MA
    Bioorg Med Chem; 2020 Jul; 28(13):115525. PubMed ID: 32371117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death.
    Ratushny V; Pathak HB; Beeharry N; Tikhmyanova N; Xiao F; Li T; Litwin S; Connolly DC; Yen TJ; Weiner LM; Godwin AK; Golemis EA
    Oncogene; 2012 Mar; 31(10):1217-27. PubMed ID: 21785464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer.
    Ton AT; Singh K; Morin H; Ban F; Leblanc E; Lee J; Lallous N; Cherkasov A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of small molecule inhibitors of the Aurora-A/TPX2 complex.
    Asteriti IA; Daidone F; Colotti G; Rinaldo S; Lavia P; Guarguaglini G; Paiardini A
    Oncotarget; 2017 May; 8(19):32117-32133. PubMed ID: 28389630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the non-mitotic functions of Aurora kinase A: more than just cell division.
    Bertolin G; Tramier M
    Cell Mol Life Sci; 2020 Mar; 77(6):1031-1047. PubMed ID: 31562563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.
    Lee SY; Kim EY; Kim KH; Lee KA
    Cell Cycle; 2016 Dec; 15(23):3296-3305. PubMed ID: 27753540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Wang NJ; Zhao RJ; Zhou SF
    Drug Des Devel Ther; 2015; 9():487-508. PubMed ID: 25609923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.
    Korobeynikov V; Borakove M; Feng Y; Wuest WM; Koval AB; Nikonova AS; Serebriiskii I; Chernoff J; Borges VF; Golemis EA; Shagisultanova E
    Breast Cancer Res Treat; 2019 Sep; 177(2):369-382. PubMed ID: 31254157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AURKA destruction is decoupled from its activity at mitotic exit but is essential to suppress interphase activity.
    Abdelbaki A; Akman HB; Poteau M; Grant R; Gavet O; Guarguaglini G; Lindon C
    J Cell Sci; 2020 Jun; 133(12):. PubMed ID: 32393600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.